| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,810.00
|
|
Change (%)
|
-10.00 (-0.55%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,792.65
-
1,828.10
|
|
52-Week Range (RS)
|
1,583.60
-
2,047.55
|
|
Beta (1 Year)
|
0.44
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc. |
| Sun Pharmaceutical Industries Ltd drops for fifth straight session |
| Sun Pharma incorporates subsidiary in IFSC, Gift City |
| Sun Pharma update on Lipitor antitrust litigation in US court |
| Sun Pharma receives favorable court ruling in Lipitor patent settlement case in US |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
24-Sep-2026 |
1853.00 |
-2.32 |
| 1Month |
01-Sep-2026 |
1930.45 |
-6.24 |
| 3Month |
01-Jul-2026 |
1865.95 |
-3.00 |
| 6Month |
01-Apr-2026 |
1728.45 |
4.72 |
| 1Year |
01-Oct-2025 |
1636.15 |
10.63 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.91 |
4076.55 |
| SBI BSE SENSEX ETF |
2.32 |
2823.56 |
| ICICI Pru Value Fund |
4.55 |
2733.05 |
| ICICI Pru Aggressive Hybrid Fund |
3.73 |
1955.63 |
| ICICI Pru Large Cap Fund |
2.24 |
1799.97 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Zydus Lifesciences Ltd |
1,145.25 |
-1.56 |
1,232.00 |
835.85 |
114,239.13 |
| Cipla Ltd |
1,346.85 |
-0.23 |
1,672.20 |
1,165.55 |
108,808.05 |
| Laurus Labs Ltd |
1,989.00 |
0.37 |
2,054.55 |
838.40 |
107,468.10 |
| Mankind Pharma Ltd |
2,527.00 |
0.88 |
2,640.30 |
1,909.90 |
104,376.49 |
| Dr Reddys Laboratories Ltd |
1,200.10 |
-2.90 |
1,414.40 |
1,080.05 |
100,169.98 |
|
|
|
|